United States: Healthcare Goes Digital But Regulation Hard To Disrupt

Last Updated: November 7 2017
Article by Toby Patten and Neil O'Flaherty

Healthcare technology is at a pivotal moment in its development. The healthcare industry is primed to take advantage of the innovative tools that technology can provide and governments are positive as to the potential healthcare cost savings that are expected to follow. Regulators around the world are increasingly starting to acknowledge that conventional approaches to regulation may act as an impediment to digital innovation in healthcare and are looking to modernise health regulation. But we are still a long way off an environment where regulation has caught up with technology.

Digitisation of healthcare

Across the world technology is changing the way that healthcare is provided. The adoption of digital health technologies is helping medical practitioners to perform complex procedures, administer medicines with fewer errors and monitor and care for patients in a more consistent and effective manner.1 Researchers have also concluded that the digitisation of healthcare can improve drug development and supply-chain management.2 Governments are also looking to fully digitise health services by implementing digital initiatives such as online health record systems and secure digital channels to improve the continuity and coordination of treatments.3

Digital disruption in healthcare and the role of regulators

Improvements to health services, facilitated by the uptake of digital health technologies, is commonly linked to the idea that digital disruption in healthcare is occurring. These benefits are typically measured by the cost savings and increased efficiencies that result from the use of technology in health services, for example eliminating the costs spent on incorrect or unnecessary treatment.4 It is not so clear, however, that there is true disruption when it comes to how government regulators are reacting to new technologies in healthcare.

Innovation in healthcare can be difficult due to the high risk and costs associated with developing therapeutic products. Strict regulatory requirements exist, intended to apply safety and efficacy standards to all therapeutic products, and criticism is regularly leveled at regulators for perceived delays and unwillingness to change their historical approaches to fulfilling public health mandates. For example, traditionally regulation as well as safety and efficacy assessments of medical devices have centred on the devices meeting conformity standards and manufacturers supplying extensive safety and efficacy testing data, often from clinical trials, to regulators. Now the industry has to contend with the extremely fast-growing emergence of a multitude of beneficial health apps and wearable health technologies. With such exponential growth, traditional means for assessing the safety and efficacy of an app or a wearable personal health device arguably are out of step with ongoing evolutions in those technologies.

Regulators are acknowledging that analogue-based regulations do not support digital change.5 Certain countries are beginning to embrace digital change to health services by implementing national digital strategies (Australia) or amending existing laws and policies to limit what is defined and/or actively regulated as a medical device (US). But governments and authorities acknowledge that more can be done to provide a flexible framework for this level of innovation. For example, the U.S. Food and Drug Administration (FDA) has acknowledged the potential of enormous amounts of health and medical "real world data" (RWD) generated by digital health products: these potentially can be organized and analysed to support in whole or in part medical device marketing authorization deliberations and other regulatory decision-making in lieu of traditional means of safety and effectiveness data gathering and analysis. In this respect the U.S FDA is looking for ways to utilise RWD more effectively in its regulatory processes. The U.S. FDA is also looking to develop new programs which would pre-certify the quality and validation practices of certain developers of medical device software products, to avoid assessing these practices for each device reviewed by the FDA for marketing authorisation.

Internationally, efforts are also underway to accelerate the harmonisation and convergence of medical device regulations. Members of the International Medical Device Regulators Forum (IMDRF) meet regularly to produce harmonised principles that act as guidance for individual jurisdictions. However this guidance extends only to the regulation of medical devices, leaving those categories of health-related apps or programs seen as non-devices, subject to the regulatory and enforcement discretion of individual jurisdictions.

What does this mean for health tech companies?

While we are seeing regulators looking to modernise and harmonise health regulation, health regulation is still fragmented and lagging behind digital developments in health tech. This presents companies operating in this space with both opportunities and challenges.

Understanding existing regulatory frameworks presents health tech companies with the opportunity to design the functions and claims of their health-related apps, wearable technologies and other software devices, to avoid or minimise active regulation as a medical device. Further, with health technology outpacing regulatory development, there is scope for health tech companies to play an active part in development discussions with governments and ultimately shape future regulatory frameworks.

To the extent that regulators have greater access to RWD to streamline regulatory processes, health tech companies face challenges in retaining primary control of important data sets that detail product safety and effectiveness. Historically, reliant on the data provided by manufacturers and other regulated parties, regulatory authorities that can collect and analyse RWD will be less dependent on this flow of product information from manufacturers and other regulated parties. Regulators will have significant amounts of RWD at their direct disposal, which could result in quicker and more unilateral decision-making and regulatory action where a product safety or efficacy issue is perceived. Without an opportunity for meaningful consultation, health tech companies may be placed in the unenviable position of having to react to agency demands for action or additional information after the regulator has already formed an opinion on the issue.

For the moment health tech companies must continue working within existing regulations whilst also being ready to embrace developing regulatory changes which foster innovation and faster market access for digital health technologies.


1 Peter Newman, 'Digital Disruption in Healthcare: The $8.7 trillion opportunity in digital health,' Business Insider Intelligence Report, 15 May 2017

2 https://www.morganstanley.com/ideas/digital-disruption-drugs-healthcare-sectors-bluepaper

3 Toby Patten and Rowena Baer, 'Strategic Change: the digitisation of Australian healthcare,' Digital Health Legal, October 2017.

4 'A digital revolution in health care is speeding up' The Economist, March 2017

5 'Digital and disrupted: all change for healthcare' Roland Berger report, September 2016

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions